If any alcohol has been consumed, call a rideshare, arrange a designated driver, or wait the necessary time for BAC to reach zero
Also noteworthy earlier this month was the publication of a Phase 2 randomized trial in 272 participants without diabetes of orforglipron, an oral GLP-1 agonist, which achieved a 14.7% weight loss (placebo-adjusted 12.3%) at the highest dose With that brief review of the latest trials and drugs, lets turn to clinical outcomes, for which most are taking us back to single agonistGLP-1drugs
Comparison of four groups were performed using two-way ANOVA followed by Bonferroni post-test
Lam LKM, Murphy S, Kokkinaki D, Venosa A, Sherrill-Mix S, Casu C, et al
These SCFAs directly stimulate L-cells to release GLP-1
Image credit: Pexels in 1 year Data sourced from 373,000 weight tracker entries in the Juniper app No GP referral Ongoing expert support Trusted by 260,000 members worldwide *First month pricing for a 6 mo commitment